142 related articles for article (PubMed ID: 21174006)
1. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome.
Rodríguez-González R; Millán M; Sobrino T; Miranda E; Brea D; de la Ossa NP; Blanco M; Perez J; Dorado L; Castellanos M; Lomas DA; Moro MA; Dávalos A; Castillo J
Thromb Haemost; 2011 Mar; 105(3):421-9. PubMed ID: 21174006
[TBL] [Abstract][Full Text] [Related]
2. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.
Rodríguez-González R; Agulla J; Pérez-Mato M; Sobrino T; Castillo J
Neurochem Int; 2011 Feb; 58(3):337-43. PubMed ID: 21163314
[TBL] [Abstract][Full Text] [Related]
5. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Thromb Haemost; 2004 Mar; 91(3):457-64. PubMed ID: 14983220
[TBL] [Abstract][Full Text] [Related]
6. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke.
Rodríguez-González R; Sobrino T; Rodríguez-Yáñez M; Millán M; Brea D; Miranda E; Moldes O; Pérez J; Lomas DA; Leira R; Dávalos A; Castillo J
J Transl Med; 2011 May; 9():58. PubMed ID: 21569344
[TBL] [Abstract][Full Text] [Related]
7. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.
Yepes M; Sandkvist M; Wong MK; Coleman TA; Smith E; Cohan SL; Lawrence DA
Blood; 2000 Jul; 96(2):569-76. PubMed ID: 10887120
[TBL] [Abstract][Full Text] [Related]
8. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
[TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system?
Yepes M; Lawrence DA
Trends Cardiovasc Med; 2004 Jul; 14(5):173-80. PubMed ID: 15261888
[TBL] [Abstract][Full Text] [Related]
10. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.
Lebeurrier N; Liot G; Lopez-Atalaya JP; Orset C; Fernandez-Monreal M; Sonderegger P; Ali C; Vivien D
Mol Cell Neurosci; 2005 Dec; 30(4):552-8. PubMed ID: 16209928
[TBL] [Abstract][Full Text] [Related]
11. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
[TBL] [Abstract][Full Text] [Related]
12. Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.
Hill RM; Parmar PK; Coates LC; Mezey E; Pearson JF; Birch NP
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):595-601. PubMed ID: 10642518
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.
Torrente D; Su EJ; Fredriksson L; Warnock M; Bushart D; Mann KM; Emal CD; Lawrence DA
Transl Stroke Res; 2022 Oct; 13(5):801-815. PubMed ID: 35122213
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke.
Wu W; Asakawa T; Yang Q; Zhao J; Lu L; Luo Y; Gong P; Han S; Li W; Namba H; Wang L
Neurol Res; 2017 Oct; 39(10):862-868. PubMed ID: 28738762
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation.
Gelderblom M; Neumann M; Ludewig P; Bernreuther C; Krasemann S; Arunachalam P; Gerloff C; Glatzel M; Magnus T
PLoS One; 2013; 8(5):e63118. PubMed ID: 23658802
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system.
Teesalu T; Kulla A; Simisker A; Sirén V; Lawrence DA; Asser T; Vaheri A
Thromb Haemost; 2004 Aug; 92(2):358-68. PubMed ID: 15269833
[TBL] [Abstract][Full Text] [Related]
18. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435
[TBL] [Abstract][Full Text] [Related]
19. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival.
Hastings GA; Coleman TA; Haudenschild CC; Stefansson S; Smith EP; Barthlow R; Cherry S; Sandkvist M; Lawrence DA
J Biol Chem; 1997 Dec; 272(52):33062-7. PubMed ID: 9407089
[TBL] [Abstract][Full Text] [Related]
20. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
